Share on StockTwits

Receptos (NASDAQ:RCPT) CAO David A. Hinkle unloaded 3,000 shares of the stock on the open market in a transaction dated Wednesday, August 13th. The stock was sold at an average price of $42.69, for a total transaction of $128,070.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Receptos (NASDAQ:RCPT) traded up 1.48% on Thursday, hitting $46.53. The stock had a trading volume of 347,993 shares. Receptos has a 1-year low of $15.21 and a 1-year high of $55.00. The stock has a 50-day moving average of $40.41 and a 200-day moving average of $39.22. The company’s market cap is $1.032 billion.

Receptos (NASDAQ:RCPT) last announced its earnings results on Tuesday, August 12th. The company reported ($1.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.85) by $0.19. The company had revenue of $1.10 million for the quarter, compared to the consensus estimate of $1.28 million. On average, analysts predict that Receptos will post $-3.98 earnings per share for the current fiscal year.

A number of analysts have recently weighed in on RCPT shares. Analysts at Leerink Swann initiated coverage on shares of Receptos in a research note on Wednesday. They set an “outperform” rating and a $60.00 price target on the stock. Separately, analysts at Nomura initiated coverage on shares of Receptos in a research note on Monday, June 30th. They set a “buy” rating and a $63.00 price target on the stock. Finally, analysts at BMO Capital Markets set a $58.00 price target on shares of Receptos in a research note on Tuesday, June 10th. Three investment analysts have rated the stock with a buy rating, The stock has an average rating of “Buy” and a consensus target price of $55.00.

Receptos, Inc (NASDAQ:RCPT) is a biopharmaceutical company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.